On the BSE, the stock finished at Rs 417.95, declining 5.23 percent with volume of 5.69 lakh shares. Suraksha Diagnostic launched its Rs 846-crore initial share sale last week, which was subscribed ...

The stock made its debut at Rs 437, registering a decline of 0.90 per cent from the issue price on the BSE. During the day, ...

The CSE was barred by the Securities and Exchange Board of India in 2013 due to regulatory and compliance issues.

ITAT Mumbai held that addition under section 68 of the Income Tax Act made towards penny stock deleted since assessee duly discharged the onus cast upon him and there is no adverse order/penalty order ...

In August 2024 the Calcutta High Court gave CSE six more months to comply with Sebi's Exit Policy, which mandates stricter ...

The diagnostic chain's Rs 846-crore IPO made a tepid debut, listing at Rs 437 on BSE and sliding to Rs 426.65 amidst cautious investor sentiment.

Shares of Suraksha Diagnostic Ltd listed with a discount of nearly 1 per cent against the issue price of Rs 441 on Friday.The stock made its debut at Rs 437, ...

Suraksha Diagnostic shares listed at a discount of nearly 1% on their market debut. The stock opened at Rs 437, down 0.90% from the issue price, and further declined. Learn more.

Kolkata-based Suraksha Diagnostic sold its IPO in the price band of Rs 420-441 per share with a lot size of 34 shares, which was open for bidding between November 29 and December 03.

Vodafone sold its final 3% stake in Indus Towers for Rs 2,801.7 crore. Multiple global investors purchased the shares. Vodafone will use some proceeds to repay debt. The remaining amount will be ...